StockNews.com downgraded shares of Edap Tms (NASDAQ:EDAP – Free Report) from a hold rating to a sell rating in a research report report published on Monday morning.
Separately, HC Wainwright reissued a “buy” rating and issued a $19.00 price target on shares of Edap Tms in a research note on Thursday, August 29th.
Get Our Latest Analysis on Edap Tms
Edap Tms Price Performance
Edap Tms (NASDAQ:EDAP – Get Free Report) last announced its quarterly earnings data on Wednesday, August 28th. The medical equipment provider reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.04). The business had revenue of $16.97 million for the quarter, compared to analysts’ expectations of $17.16 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. On average, equities analysts anticipate that Edap Tms will post -0.6 EPS for the current fiscal year.
Institutional Investors Weigh In On Edap Tms
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Redhawk Wealth Advisors Inc. acquired a new stake in shares of Edap Tms during the third quarter worth about $36,000. BNP Paribas Financial Markets lifted its holdings in Edap Tms by 23.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after buying an additional 4,400 shares in the last quarter. Virtu Financial LLC purchased a new position in Edap Tms in the 1st quarter valued at approximately $82,000. Orion Capital Management LLC grew its stake in shares of Edap Tms by 10.4% in the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after acquiring an additional 6,600 shares in the last quarter. Finally, Commonwealth Equity Services LLC increased its position in shares of Edap Tms by 5.9% during the second quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock worth $388,000 after acquiring an additional 4,000 shares during the period. 62.74% of the stock is owned by hedge funds and other institutional investors.
Edap Tms Company Profile
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.
Further Reading
- Five stocks we like better than Edap Tms
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- Stock Sentiment Analysis: How it Works
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- The 3 Best Blue-Chip Stocks to Buy Now
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.